Treatment of patients with familial defective apolipoprotein B-100 with pravastatin and gemfibrozil: a two-period cross-over study
- 1 December 1994
- journal article
- clinical trial
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 72 (12) , 1065-1070
- https://doi.org/10.1007/bf00577757
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Characteristics of 46 heterozygous carriers and 57 unaffected relatives in five Danish families with familial defective apolipoprotein B-100.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Apolipoprotein(a) polymorphism predicts the increase of Lp(a) by pravastatin in patients with familial hypercholesterolaemia treated with bile acid sequestrationEuropean Journal of Clinical Investigation, 1993
- A multicenter comparative trial of lovastatin and pravastatin in the treatment of hypercholesterolemiaThe American Journal of Cardiology, 1993
- Hypocholesterolemic effects of cholestyramine and colestipol in patients with familial defective apolipoprotein B-100Atherosclerosis, 1993
- Hypocholesterolaemic effects of lovastatin in familial defective apolipoprotein B-100The Lancet, 1992
- Familial defective apolipoprotein B100: clinical characteristics of 54 casesAtherosclerosis, 1992
- Response to cholesterol-lowering drugs in familial defective apolipoprotein B-100Atherosclerosis, 1991
- Low density lipoprotein density and composition in hypercholesterolaemic men treated with HMG CoA reductase inhibitors and gemfibrozilJournal of Internal Medicine, 1991
- Influence of lovastatin on concentrations and composition of lipoprotein subfractionsAtherosclerosis, 1990
- Familial defective apolipoprotein B-100. Comparison with familial hypercholesterolemia in 18 cases detected in Munich.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990